Skip to main content

VIDEO: Alzheimer’s disease, clinical trials, and COVID-19 with Dr. Daniel Gillen


UCI MIND Facebook LIVE Video Series

This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention.

Alzheimer’s disease, clinical trials, and COVID-19


About the Speaker:

Dr. Gillen received his PhD in Biostatistics from the University of Washington and leads the Data Management and Statistics Core for UCI MIND’s NIH-designated Alzheimer’s Disease Research Center. He is a gifted trialist and widely recognized for his work in the design and analysis of clinical trials for Alzheimer’s disease and other health conditions. Dr. Gillen serves on numerous Data Safety and Monitoring Boards, evaluating the safety of ongoing clinical trials nationally and internationally, and he has participated on multiple FDA advisory panels that are instrumental in deciding which drugs get approved and which do not.


We hope you join us for future episodes on the first Friday of each month at 11 AM PST. And next month, June 5th, I’ll be joined by the Dean of the UCI School of Biological Sciences and Director of the UCI Alzheimer’s Disease Research Center, Dr. Frank LaFerla.

In the meantime, to read daily updates about Alzheimer’s research and relevant COVID-19 information, please visit our blog at – though our in-person education events have been postponed, we will continue to be in touch via our blog and social media accounts

Lastly, if you’d like to help our researchers by participating in important studies in the near future, you can sign up for the UCI C2C Registry to be contacted about studies that might be right for you at

Upcoming 2020 Videos: